Psoriasis is a chronic autoimmune inflammatory disease that remains active for a long
period, even for life in most patients. The impact of psoriasis on health is not only limited to …

Twenty to thirty percent of psoriasis (Pso) patients will develop psoriatic arthritis (PsA).
Detection of Pso patients that are (at risk for) developing PsA is essential to prevent …

Objectives Non-alcoholic fatty liver disease (NAFLD), potentially evolving into liver fibrosis
(LF), is frequent in psoriasis (PsO), but data in psoriatic arthritis (PsA) are lacking. Our study …

Objective. To determine the characteristics of patients with psoriatic arthritis (PsA) who have
hyperuricemia (HUC) and their outcomes, especially cardiovascular (CVD) and kidney …

Purpose Psoriasis is an immune-mediated chronic inflammatory disease. Metabolic
syndrome (MetS) is characterized by central obesity, hypertension, dyslipidemia, diabetes …

Background: Our earlier meta-analysis showed that the correlation between psoriasis and
hyperuricemia might be region-dependent and that hyperuricemia was more common in …

Psoriasis (Pso) is a chronic inflammatory immune-mediated skin disease associated with
several comorbidities. Despite the growing number of studies providing evidence for the link …

Background Psoriasis is a chronic inflammatory and papulosquamous dermatological
disorder. While previous studies have discussed certain inflammatory markers for …

Psoriasis mimics uric acid in terms of inflammation, but the association has not been well
defined. This study aimed to identify the causal link between serum uric acid (SUA) and …

Purpose This prospective observational study investigated whether interleukin (IL)-17A
inhibitors could reduce serum uric acid (SUA) levels in psoriatic patients with hyperuricemia …